Your browser doesn't support javascript.
loading
[Management of toxicities of BRAF inhibitors and MEK inhibitors in advanced melanoma]. / Gestion des toxicités des inhibiteurs BRAF et MEK dans le mélanome métastatique.
Sibaud, Vincent; Baric, Lilian; Cantagrel, Alain; Di Palma, Mario; Ederhy, Stéphane; Paques, Michel; Perlemuter, Gabriel.
Affiliation
  • Sibaud V; Institut universitaire du cancer Toulouse - Oncopole, départements d'oncologie médicale et oncodermatologie, Toulouse, France. Electronic address: sibaud.vincent@iuct-oncopole.fr.
  • Baric L; Institut universitaire du cancer Toulouse - Oncopole, départements d'oncologie médicale et oncodermatologie, Toulouse, France.
  • Cantagrel A; Hôpital Pierre-Paul-Riquet, CHU de Purpan, centre de rhumatologie, Toulouse, France.
  • Di Palma M; Hôpital américain de Paris, service d'oncologie médicale, Neuilly-sur-Seine, France.
  • Ederhy S; AP-HP, hôpital Saint-Antoine, service de cardiologie, unité de cardio-oncologie, groupe de recherche clinique en cardio-oncologie, Paris, France.
  • Paques M; Sorbonne Université, centre hospitalier national d'ophtalmologie des Quinze-Vingts, Paris, France.
  • Perlemuter G; AP-HP, hôpital Antoine-Béclère, service d'hépato-gastroentérologie et nutrition, 92140 Clamart, France; Université Paris-Saclay, inflammation, microbiome and immunosurveillance, Inserm U996, 92140 Clamart, France.
Bull Cancer ; 108(5): 528-543, 2021 May.
Article in Fr | MEDLINE | ID: mdl-33812673
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Mitogen-Activated Protein Kinase Kinases / Proto-Oncogene Proteins B-raf / Melanoma Type of study: Guideline Limits: Humans Language: Fr Journal: Bull Cancer Year: 2021 Document type: Article Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Mitogen-Activated Protein Kinase Kinases / Proto-Oncogene Proteins B-raf / Melanoma Type of study: Guideline Limits: Humans Language: Fr Journal: Bull Cancer Year: 2021 Document type: Article Country of publication: France